A COVID-19 vaccine born in Houston has been given the go-ahead to be produced and distributed in Indonesia.

PT Bio Farma, which oversees government-owned pharmaceutical manufacturers in Indonesia, says it is set to produce 20 million doses of the IndoVac COVID-19 vaccine this year and 100 million doses a year by 2024. This comes after for the vaccine to receive authorization from Indonesia. Food and Drug Authority for emergency use in adults.

With more than 275 million inhabitants, Indonesia is the fourth most populous country in the world.

IndoVac was created by the Texas Children’s Hospital Center for Vaccine Development and Baylor College of Medicine. Drs. Peter Hotez and Maria Elena Bottazzi lead the vaccine project. Bio Farma is licensing IndoVac from BCM Ventures, the trading group of…